Januvia

Rediff.com » News » Januvia

News for Januvia

Business

Price relief for diabetes patients as drugs go off patent

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category......

Merck & Co wins injunction against Indian firm over diabetes drugs

MSD, a unit of US drugmaker Merck & Co, said it has won an injunction against India's Aprica Pharmaceuticals and a source said this will stop Aprica launching generic versions of two diabetes drugs......

Should pharma MNCs be peeved?

To conclude from the judgment that the country has scant respect for patents appears far-fetched, notes Bhupesh Bhandari.Multinational pharmaceutical companies complain that India has become a......

Drug patent row: HC to hear US co on Apr 12

Delhi High Court on Wednesday posted for April 12 an appeal filed by US pharmaceuticals major Merck Sharp and Dohme against the single judge bench order refusing to restrain Indian firm Glenmark......

Patent row: HC refuses interim relief to Merck

The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme which sought a restraint on Indian firm Glenmark Pharmaceuticals on......

Rediff News

Januvia

News for Januvia

Price relief for diabetes patients as drugs go off patent

Merck & Co wins injunction against Indian firm over diabetes drugs

Should pharma MNCs be peeved?

Drug patent row: HC to hear US co on Apr 12

Patent row: HC refuses interim relief to Merck

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS